TGTX
#1019
TG Therapeutics, Inc. - Common Stock
55.7 2 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.25%
Variación mensual
+1.55%
Variación en los últimos 6 meses
+89.59%
Cambio anual
+92.01%
Cierres anteriores
55.0 3
Open
55.7 2
Mínimo
55.7 2
Máximo
55.7 2
Volumen
114
Financials
- Market Capitalization 8.53 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
10.76
Relación precio/flujo de caja
7.81
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 993 |  ABVX Abivax SA - American Depositary Shares | 114.30 USD | -1.91% | -2.88% | -8.49% | +39.39% | 8.98 B USD | ||
| 998 |  IBRX ImmunityBio, Inc. - Common Stock | 8.40 USD | +1.82% | +7.01% | +20.00% | +258.97% | 8.90 B USD | ||
| 1032 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.96 USD | +0.01% | +0.11% | +0.60% | +151.84% | 8.39 B USD | ||
| 1041 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.62 USD | +0.01% | -13.99% | -5.80% | +291.55% | 8.25 B USD |